Mucopolysaccharidosis type 2

A lysosomal storage disease with multisystemic involvement leading to a massive accumulation of glycosaminoglycans and a wide variety of symptoms including distinctive coarse facial features, short stature, cardio-respiratory involvement and skeletal abnormalities. It manifests as a continuum varying from a severe form with neurodegeneration to an attenuated form without neuronal involvement.

Global developmental delay

A delay in the achievement of motor or mental milestones in the domains of development of a child, including motor skills, speech and language, cognitive skills, and social and emotional skills. This term should only be used to describe children younger than five years of age.


Total: 2

                      


(per page)
PMID (PMCID)
23634718
(3643848)
FEMALE
Deletion Xq27.3q28 in female patient with global developmental delays and skewed X-inactivation.
Marshall LS, Simon J, Wood T, Peng M, Owen R, Feldman GS, Zaragoza MV.
BMC Med Genet. 2013;14:49.
Global developmental delay and mental retardation are associated with X-linked disorders including Hunter syndrome (mucopolysaccharidosis type II) and Fragile X syndrome (FXS).
23634718
(3643848)
FEMALE
Deletion Xq27.3q28 in female patient with global developmental delays and skewed X-inactivation.
Marshall LS, Simon J, Wood T, Peng M, Owen R, Feldman GS, Zaragoza MV.
BMC Med Genet. 2013;14:49.
Global developmental delay and mental retardation are associated with X-linked disorders including Hunter syndrome (mucopolysaccharidosis type II) and Fragile X syndrome (FXS).